AxoGen Announces Closing of Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
AxoGen, Inc. (AXGN) PT Raised to $27 at Wedbush Following Investor Day
November 21, 2017 9:44 AM ESTWedbush raised its price target on AxoGen, Inc. (NASDAQ: AXGN) to $27.00 (from $22.00) while maintaining a Outperform rating following the company's investor day. Analyst Tao Levy came away with greater confidence and clarity around the company's new market opportunities within peripheral nerve repair.
Management... More
AxoGen, Inc. (AXGN) PT Raised to $27 at JMP Securities Following Analyst Day
November 21, 2017 8:04 AM ESTJMP Securities raised its price target on AxoGen, Inc. (NASDAQ: AXGN) to $27.00 (from $25.00) while maintaining a Market Outperform rating following the company's analyst day. JMP's new $27 target is based on 8-9x EV/Sales on 2019 revenue estimates of $105 mln.
The company continued... More



